Pharma News

EmpowerPharm Finishes Phase II Trial on Potential CBD Treatment for Social Anxiety Disorder

The trial of a pharmaceutical-grade CBD for social anxiety disorder, which was the first of its kind to be approved by the FDA, is expected to receive top line results next month.

Source link
#EmpowerPharm #Finishes #Phase #Trial #Potential #CBD #Treatment #Social #Anxiety #Disorder

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *